⌘K

Home/Filings/4/0001213900-18-015548

4//SEC Filing

Stilley William B. III 4

Accession 0001213900-18-015548

CIK 0001513525other

View on SEC.gov Company Profile

Filed

Nov 12, 7:00 PM ET

Accepted

Nov 13, 6:05 PM ET

Size

10.0 KB

Accession

0001213900-18-015548

Insider Transaction Report

Form 4

Period: 2018-11-12

ADIAL PHARMACEUTICALS, INC.ADIL

Stilley William B. III

DirectorChief Executive Officer10% Owner

Transactions

Other
Warrant to purchase common stock
2018-11-12+36,800→ 36,800 total
Exercise: $5.00From: 2018-11-12Exp: 2023-07-31→ Common Stock (36,800 underlying)
Other
Warrant to purchase common stock
2018-11-12+36,800→ 36,800 total
Exercise: $6.25From: 2018-11-12Exp: 2023-07-31→ Common Stock (36,800 underlying)
Other
Warrant to purchase units
2018-11-12−36,800→ 0 total
Exercise: $5.00From: 2018-07-31Exp: 2023-07-31→ Units (73,600 underlying)

Footnotes (1)

[F1]On November 12, 2018, Mr. Stilley exchanged a warrant to purchase 36,800 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 36,800 shares of common stock.

Documents

1 file

4
ownership.xmlPrimary

Issuer

ADIAL PHARMACEUTICALS, INC.

CIK 0001513525

Entity typeother

Related Parties

1

filerCIK 0001718069

Filing Metadata

Form type: 4
Filed: Nov 12, 7:00 PM ET
Accepted: Nov 13, 6:05 PM ET
Size: 10.0 KB

View on SEC.gov